Engineering a growth factor embedded nanofiber matrix niche to promote vascularization for functional cardiac regeneration.

The major loss of tissue extracellular matrix (ECM) after myocardial ischemia is a serious burden that gradually leads to heart failure. Due to lack of available treatment methods to restore the cardiac function, various research strategies have come up to treat the ischemic myocardium. However these have met with limited success due to the complexity of the cardiac tissue, which exhibits a nanofibrous collagenous matrix with spatio-temporal localization of a combination of growth factors. To mimic the topographical and chemical cues of the natural cardiac tissue, we have fabricated a growth factor embedded nanofibrous scaffold through electrospinning. In our previous work, we have reported a nanofibrous matrix made of PLCL and PEOz with an average diameter of 500 nm. The scaffold properties were specifically characterized in vitro for cardio-compatibility. In the present study, we have loaded dual growth factors VEGF and bFGF in the nanofiber matrix and investigated its suitability for cardiac tissue engineering. The encapsulation and release of dual growth factors from the matrix were studied using XPS and ELISA. Bioactivity of the loaded growth factors towards proliferation and migration of endothelial cells (HUVECs) was evaluated through MTS and Boyden chamber assays respectively. The efficiency of growth factors on the nanofibrous matrix to activate signaling molecules was studied in HUVECs through gene expression analysis. Preclinical evaluation of the growth factor embedded nanofibrous patch in a rabbit acute myocardial infarction (AMI) model was studied and cardiac function assessment was made through ECG and echocardiography. The evidence for angiogenesis in the patch secured regions was analyzed through histopathology and immunohistochemistry. Our results confirm the effectiveness of growth factor embedded nanofiber matrix in restoration of cardiac function after ischemia when compared to conventional patch material thereby exhibiting promise as a valuable therapeutic solution to treat ischemic disorders.

[1]  J. LaManna,et al.  Hypoxic Regulation of Angiopoietin-2 Expression in Endothelial Cells* , 2004, Journal of Biological Chemistry.

[2]  Diana C. Canseco,et al.  Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family , 2012, Proceedings of the National Academy of Sciences.

[3]  T. Kissel,et al.  Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid). , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[4]  K. Hruska,et al.  Rho family GTPases regulate VEGF-stimulated endothelial cell motility. , 2001, Experimental cell research.

[5]  Yao Sun.  Myocardial repair/remodelling following infarction: roles of local factors. , 2008, Cardiovascular research.

[6]  Xiaojun Yu,et al.  Polycaprolactone and bovine serum albumin based nanofibers for controlled release of nerve growth factor. , 2009, Biomacromolecules.

[7]  D. Vestweber,et al.  VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[8]  U. Krishnan,et al.  Axially aligned 3D nanofibrous grafts of PLA–PCL for small diameter cardiovascular applications , 2014, Journal of biomaterials science. Polymer edition.

[9]  R. Foley,et al.  Images in nephrology. Left ventricular disorders detected by M-mode echocardiography in chronic uraemia. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  S. Homma,et al.  Cardiomyocyte Aldose Reductase Causes Heart Failure and Impairs Recovery from Ischemia , 2012, PloS one.

[11]  Dhakshinamoorthy Sundaramurthi,et al.  Biocompatibility of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanofibers for skin tissue engineering. , 2013, Journal of biomedical nanotechnology.

[12]  Kinam Park,et al.  Control of encapsulation efficiency and initial burst in polymeric microparticle systems , 2004, Archives of pharmacal research.

[13]  Ruili Huang,et al.  Identification of chemical compounds that induce HIF-1alpha activity. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  I. Tessaro,et al.  Isolation, growth and differentiation of equine mesenchymal stem cells: effect of donor, source, amount of tissue and supplementation with basic fibroblast growth factor , 2009, Veterinary Research Communications.

[15]  Kenji Nakamura,et al.  Membrane Fixation of Vascular Endothelial Growth Factor Receptor 1 Ligand-Binding Domain Is Important for Vasculogenesis and Angiogenesis in Mice , 2005, Molecular and Cellular Biology.

[16]  H. Kim,et al.  Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration , 2010, Journal of tissue engineering.

[17]  L. Orci,et al.  Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. , 1992, Biochemical and biophysical research communications.

[18]  D. Hammer,et al.  Assembly of Human Umbilical Vein Endothelial Cells on Compliant Hydrogels , 2010, Cellular and molecular bioengineering.

[19]  Kirthanashri S. Vasanthan,et al.  Development and evaluation of axially aligned nanofibres for blood vessel tissue engineering , 2014, Journal of tissue engineering and regenerative medicine.

[20]  J. Benoit,et al.  How to achieve sustained and complete protein release from PLGA-based microparticles? , 2008, International journal of pharmaceutics.

[21]  V. V. van Hinsbergh,et al.  Involvement of RhoA/Rho Kinase Signaling in VEGF-Induced Endothelial Cell Migration and Angiogenesis In Vitro , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[22]  T. Sakurai,et al.  Role of fibroblast growth factor signaling in vascular formation and maintenance: orchestrating signaling networks as an integrated system , 2012, Wiley interdisciplinary reviews. Systems biology and medicine.

[23]  U. Krishnan,et al.  Multidimensional nanofibrous scaffolds of poly(lactide-co-caprolactone) and poly(ethyl oxazoline) with improved features for cardiac tissue engineering. , 2015, Nanomedicine.

[24]  C. Werner,et al.  Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hydrogels. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Simon P. Hoerstrup,et al.  Bioresorbable Scaffolds for Cardiovascular Tissue Engineering , 2014, EMJ Interventional Cardiology.

[26]  R. Sasisekharan,et al.  FGF‐2/fibroblast growth factor receptor/heparin‐like glycosaminoglycan interactions: a compensation model for FGF‐2 signaling , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  D. Mooney,et al.  Growth factor delivery-based tissue engineering: general approaches and a review of recent developments , 2011, Journal of The Royal Society Interface.

[28]  Jun Wu,et al.  Infarct stabilization and cardiac repair with a VEGF-conjugated, injectable hydrogel. , 2011, Biomaterials.

[29]  C. Xiao,et al.  Establishment of a chronic left ventricular aneurysm model in rabbit , 2014, Journal of geriatric cardiology : JGC.

[30]  Y. Ouchi,et al.  VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B–PDGFRβ signaling , 2005, Journal of Cell Science.

[31]  D. Seliktar,et al.  Enhanced infarct stabilization and neovascularization mediated by VEGF-loaded PEGylated fibrinogen hydrogel in a rodent myocardial infarction model. , 2013, Biomaterials.

[32]  C. Simonaro.  Cartilage and chondrocyte pathology in the mucopolysaccharidoses: The role of glycosaminoglycan-mediated inflammation. , 2010, Journal of pediatric rehabilitation medicine.

[33]  H. Kleinman,et al.  Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. , 1999, The American journal of pathology.

[34]  K. Bala,et al.  Effect of different mitogens and serum concentration on HUVEC morphology and characteristics: implication on use of higher passage cells. , 2011, Tissue & cell.

[35]  L. Horan,et al.  Significance of the Diagnostic Q Wave of Myocardial Infarction , 1971, Circulation.

[36]  A. Balbarini,et al.  Tissue response to poly(ether)urethane-polydimethylsiloxane-fibrin composite scaffolds for controlled delivery of pro-angiogenic growth factors. , 2010, Biomaterials.

[37]  M. Czubryt.  Common threads in cardiac fibrosis, infarct scar formation, and wound healing , 2012, Fibrogenesis & tissue repair.

[38]  H. Nader,et al.  Heparan sulfate proteoglycans: structure, protein interactions and cell signaling. , 2009, Anais da Academia Brasileira de Ciencias.

[39]  Stephane Heymans,et al.  Myocardial Extracellular Matrix: An Ever-Changing and Diverse Entity , 2014, Circulation research.

[40]  Tatiana Segura,et al.  Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells , 2010, The Journal of cell biology.

[41]  Christopher J Murphy,et al.  Early responses of vascular endothelial cells to topographic cues. , 2013, American journal of physiology. Cell physiology.

[42]  Didier Y. R. Stainier,et al.  Molecular control of endothelial cell behaviour during blood vessel morphogenesis , 2011, Nature Reviews Molecular Cell Biology.

[43]  P. Kowey,et al.  Ventricular repolarization components on the electrocardiogram: cellular basis and clinical significance. , 2003, Journal of the American College of Cardiology.

[44]  H. Kleinman,et al.  Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha. , 1999, The American journal of pathology.

[45]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[46]  W. Brady,et al.  Acute myocardial infarction—Part II , 2002, BMJ : British Medical Journal.

[47]  Zhifeng Xiao,et al.  A myocardial patch made of collagen membranes loaded with collagen-binding human vascular endothelial growth factor accelerates healing of the injured rabbit heart. , 2011, Tissue engineering. Part A.

[48]  K. Cherian,et al.  Analytical study to evaluate the extracellular matrix in processed acellular xenografts , 2010 .

[49]  Michael Kjaer,et al.  Basic components of connective tissues and extracellular matrix: elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins. , 2014, Advances in experimental medicine and biology.

[50]  J. Gutkind,et al.  VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherin , 2006, Nature Cell Biology.

[51]  C. Werner,et al.  FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis. , 2010, Biomaterials.

[52]  Sylvain Gabriele,et al.  Spatial coordination between cell and nuclear shape within micropatterned endothelial cells , 2012, Nature Communications.

[53]  Benjamin M Wu,et al.  The enhancement of VEGF-mediated angiogenesis by polycaprolactone scaffolds with surface cross-linked heparin. , 2011, Biomaterials.

[54]  L. Claesson‐Welsh,et al.  VEGF receptor signalling ? in control of vascular function , 2006, Nature Reviews Molecular Cell Biology.

[55]  I. Dixon,et al.  Cardiac Fibrosis and Heart Failure—Cause or Effect? , 2015 .

[56]  J. Lee,et al.  Recombinant growth factor mixtures induce cell cycle progression and the upregulation of type I collagen in human skin fibroblasts, resulting in the acceleration of wound healing processes. , 2014, International journal of molecular medicine.

[57]  北村 倫也.  Regulation of VEGF-mediated angiogenesis by the Akt/PKB substrate girdin , 2008 .

[58]  Napoleone Ferrara,et al.  Vascular endothelial growth factor: basic science and clinical progress. , 2004, Endocrine reviews.

[59]  Yang Wu,et al.  Integrated Effects of Matrix Mechanics and Vascular Endothelial Growth Factor (VEGF) on Capillary Sprouting , 2014, Annals of Biomedical Engineering.